AAPL354.17+22.27 (+6.71%) ▲|ABBV290.98+4.98 (+1.74%) ▲|ABT115.80+6.40 (+5.85%) ▲|ACN265.42+10.86 (+4.27%) ▲|ADBE248.70+2.56 (+1.04%) ▲|AMAT367.23-14.69 (-3.85%) ▼|AMD483.11-0.79 (-0.16%) ▼|AMGN479.06+17.80 (+3.86%) ▲|AMT192.97+5.68 (+3.03%) ▲|AMZN269.85+19.16 (+7.64%) ▲|AVGO328.55-3.58 (-1.08%) ▼|AXP331.91+6.41 (+1.97%) ▲|BA176.43+3.12 (+1.80%) ▲|BAC51.26+1.60 (+3.22%) ▲|BKNG172.66+16.99 (+10.91%) ▲|BLK1,226.83+65.51 (+5.64%) ▲|BMY63.17+1.46 (+2.37%) ▲|BNY151.80+2.49 (+1.67%) ▲|BRK-B573.67+16.60 (+2.98%) ▲|C124.67+1.96 (+1.59%) ▲|CAT583.28-40.66 (-6.52%) ▼|CL98.62+3.00 (+3.13%) ▲|CMCSA24.70+1.03 (+4.33%) ▲|COF206.73-1.98 (-0.95%) ▼|COP135.77-8.63 (-5.98%) ▼|COST1,047.09+27.83 (+2.73%) ▲|CRM226.38+4.18 (+1.88%) ▲|CSCO102.47-0.50 (-0.49%) ▼|CVS79.72-11.69 (-12.79%) ▼|CVX215.19-10.08 (-4.47%) ▼|DE674.85+9.02 (+1.35%) ▲|DHR234.53+4.42 (+1.92%) ▲|DIS119.67+5.49 (+4.81%) ▲|DUK129.58+3.07 (+2.43%) ▲|EMR171.29+4.90 (+2.94%) ▲|FDX324.63+6.61 (+2.08%) ▲|GD366.11-8.39 (-2.24%) ▼|GE331.92+11.25 (+3.51%) ▲|GEV817.75-100.46 (-10.94%) ▼|GILD174.38+6.91 (+4.13%) ▲|GM92.71+4.37 (+4.95%) ▲|GOOG290.38+12.11 (+4.35%) ▲|GOOGL291.98+11.95 (+4.27%) ▲|GS928.17+32.08 (+3.58%) ▲|HD351.94+18.28 (+5.48%) ▲|HON230.27+6.22 (+2.78%) ▲|IBM255.01+4.97 (+1.99%) ▲|INTC58.37-2.18 (-3.60%) ▼|INTU356.67+11.95 (+3.47%) ▲|ISRG484.97+44.22 (+10.03%) ▲|JNJ273.55+7.38 (+2.77%) ▲|JPM351.27+13.29 (+3.93%) ▲|KO95.91+1.11 (+1.17%) ▲|LIN525.83+14.28 (+2.79%) ▲|LLY1,421.57+12.19 (+0.86%) ▲|LMT595.60-43.40 (-6.79%) ▼|LOW228.04+14.66 (+6.87%) ▲|LRCX222.70-8.02 (-3.48%) ▼|MA668.15+20.97 (+3.24%) ▲|MCD278.17+15.13 (+5.75%) ▲|MDLZ67.74+2.62 (+4.02%) ▲|MDT105.06+6.18 (+6.24%) ▲|META635.97+14.94 (+2.41%) ▲|MMM194.30+17.25 (+9.74%) ▲|MO78.04+1.10 (+1.43%) ▲|MRK148.87+4.20 (+2.90%) ▲|MS192.83+6.74 (+3.62%) ▲|MSFT555.51+34.52 (+6.62%) ▲|MU807.80-47.30 (-5.53%) ▼|NEE88.53+4.20 (+4.98%) ▲|NFLX65.97+2.55 (+4.01%) ▲|NKE40.54+2.06 (+5.35%) ▲|NOW109.05-0.11 (-0.10%) ▼|NVDA203.89-2.80 (-1.35%) ▼|ORCL125.47-0.72 (-0.57%) ▼|PEP142.87+5.60 (+4.08%) ▲|PFE30.71+0.71 (+2.35%) ▲|PG167.12+5.06 (+3.12%) ▲|PLTR171.27-4.13 (-2.35%) ▼|PM210.67+2.64 (+1.27%) ▲|QCOM168.40+3.97 (+2.41%) ▲|RTX197.50-6.32 (-3.10%) ▼|SBUX108.51+3.74 (+3.57%) ▲|SCHW93.00+3.72 (+4.17%) ▲|SO93.23-0.52 (-0.55%) ▼|SPG227.90+5.82 (+2.62%) ▲|T21.79+0.40 (+1.85%) ▲|TMO706.09+7.75 (+1.11%) ▲|TMUS159.83+5.42 (+3.51%) ▲|TSLA389.00-9.50 (-2.38%) ▼|TXN311.09-1.41 (-0.45%) ▼|UBER71.47+4.87 (+7.31%) ▲|UNH408.87+4.43 (+1.09%) ▲|UNP307.94+4.51 (+1.48%) ▲|UPS114.06+4.89 (+4.47%) ▲|USB60.78+0.89 (+1.49%) ▲|V432.14+11.72 (+2.79%) ▲|VZ46.09+0.85 (+1.88%) ▲|WFC86.82+1.29 (+1.50%) ▲|WMT130.25+5.39 (+4.32%) ▲|XOM169.04-8.42 (-4.74%) ▼|AAPL354.17+22.27 (+6.71%) ▲|ABBV290.98+4.98 (+1.74%) ▲|ABT115.80+6.40 (+5.85%) ▲|ACN265.42+10.86 (+4.27%) ▲|ADBE248.70+2.56 (+1.04%) ▲|AMAT367.23-14.69 (-3.85%) ▼|AMD483.11-0.79 (-0.16%) ▼|AMGN479.06+17.80 (+3.86%) ▲|AMT192.97+5.68 (+3.03%) ▲|AMZN269.85+19.16 (+7.64%) ▲|AVGO328.55-3.58 (-1.08%) ▼|AXP331.91+6.41 (+1.97%) ▲|BA176.43+3.12 (+1.80%) ▲|BAC51.26+1.60 (+3.22%) ▲|BKNG172.66+16.99 (+10.91%) ▲|BLK1,226.83+65.51 (+5.64%) ▲|BMY63.17+1.46 (+2.37%) ▲|BNY151.80+2.49 (+1.67%) ▲|BRK-B573.67+16.60 (+2.98%) ▲|C124.67+1.96 (+1.59%) ▲|CAT583.28-40.66 (-6.52%) ▼|CL98.62+3.00 (+3.13%) ▲|CMCSA24.70+1.03 (+4.33%) ▲|COF206.73-1.98 (-0.95%) ▼|COP135.77-8.63 (-5.98%) ▼|COST1,047.09+27.83 (+2.73%) ▲|CRM226.38+4.18 (+1.88%) ▲|CSCO102.47-0.50 (-0.49%) ▼|CVS79.72-11.69 (-12.79%) ▼|CVX215.19-10.08 (-4.47%) ▼|DE674.85+9.02 (+1.35%) ▲|DHR234.53+4.42 (+1.92%) ▲|DIS119.67+5.49 (+4.81%) ▲|DUK129.58+3.07 (+2.43%) ▲|EMR171.29+4.90 (+2.94%) ▲|FDX324.63+6.61 (+2.08%) ▲|GD366.11-8.39 (-2.24%) ▼|GE331.92+11.25 (+3.51%) ▲|GEV817.75-100.46 (-10.94%) ▼|GILD174.38+6.91 (+4.13%) ▲|GM92.71+4.37 (+4.95%) ▲|GOOG290.38+12.11 (+4.35%) ▲|GOOGL291.98+11.95 (+4.27%) ▲|GS928.17+32.08 (+3.58%) ▲|HD351.94+18.28 (+5.48%) ▲|HON230.27+6.22 (+2.78%) ▲|IBM255.01+4.97 (+1.99%) ▲|INTC58.37-2.18 (-3.60%) ▼|INTU356.67+11.95 (+3.47%) ▲|ISRG484.97+44.22 (+10.03%) ▲|JNJ273.55+7.38 (+2.77%) ▲|JPM351.27+13.29 (+3.93%) ▲|KO95.91+1.11 (+1.17%) ▲|LIN525.83+14.28 (+2.79%) ▲|LLY1,421.57+12.19 (+0.86%) ▲|LMT595.60-43.40 (-6.79%) ▼|LOW228.04+14.66 (+6.87%) ▲|LRCX222.70-8.02 (-3.48%) ▼|MA668.15+20.97 (+3.24%) ▲|MCD278.17+15.13 (+5.75%) ▲|MDLZ67.74+2.62 (+4.02%) ▲|MDT105.06+6.18 (+6.24%) ▲|META635.97+14.94 (+2.41%) ▲|MMM194.30+17.25 (+9.74%) ▲|MO78.04+1.10 (+1.43%) ▲|MRK148.87+4.20 (+2.90%) ▲|MS192.83+6.74 (+3.62%) ▲|MSFT555.51+34.52 (+6.62%) ▲|MU807.80-47.30 (-5.53%) ▼|NEE88.53+4.20 (+4.98%) ▲|NFLX65.97+2.55 (+4.01%) ▲|NKE40.54+2.06 (+5.35%) ▲|NOW109.05-0.11 (-0.10%) ▼|NVDA203.89-2.80 (-1.35%) ▼|ORCL125.47-0.72 (-0.57%) ▼|PEP142.87+5.60 (+4.08%) ▲|PFE30.71+0.71 (+2.35%) ▲|PG167.12+5.06 (+3.12%) ▲|PLTR171.27-4.13 (-2.35%) ▼|PM210.67+2.64 (+1.27%) ▲|QCOM168.40+3.97 (+2.41%) ▲|RTX197.50-6.32 (-3.10%) ▼|SBUX108.51+3.74 (+3.57%) ▲|SCHW93.00+3.72 (+4.17%) ▲|SO93.23-0.52 (-0.55%) ▼|SPG227.90+5.82 (+2.62%) ▲|T21.79+0.40 (+1.85%) ▲|TMO706.09+7.75 (+1.11%) ▲|TMUS159.83+5.42 (+3.51%) ▲|TSLA389.00-9.50 (-2.38%) ▼|TXN311.09-1.41 (-0.45%) ▼|UBER71.47+4.87 (+7.31%) ▲|UNH408.87+4.43 (+1.09%) ▲|UNP307.94+4.51 (+1.48%) ▲|UPS114.06+4.89 (+4.47%) ▲|USB60.78+0.89 (+1.49%) ▲|V432.14+11.72 (+2.79%) ▲|VZ46.09+0.85 (+1.88%) ▲|WFC86.82+1.29 (+1.50%) ▲|WMT130.25+5.39 (+4.32%) ▲|XOM169.04-8.42 (-4.74%) ▼|
22.1 C
New York
Wednesday, November 4, 2026

Tag: press release

Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia

Conference call and webcast on Monday, June 23, 2025 at 8:00 am EDT
Conference call and webcast on Monday, June 23, 2025 at 8:00 am EDT

Wintrust Financial Corporation Announces Second Quarter and Year-to-Date 2025 Earnings Release Schedule

ROSEMONT, Ill., June 20, 2025 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation ("Wintrust") (Nasdaq: WTFC) today announced it will release second quarter and year-to-date 2025 earnings results after the market closes on Monday, July 21, 2025 and host a conference call on Tuesday, July 22, 2025 at 10:00 a.m. (CDT).

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at...

Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable reduction in Activin E resulting in fat loss with muscle preservation

DeFi Technologies Engages ShareIntel and Urvin to Enhance Market Transparency and Shareholder Intelligence

TORONTO, June 20, 2025 /PRNewswire/ - DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology...

SoCalGas Joins Forces with Labor Community Services to Help Address Hunger at 33rd Annual “Stamp Out” Hunger Food Drive

Media assets here LOS ANGELES, June 20, 2025 /PRNewswire/ -- Southern California Gas Co. (SoCalGas) once again joins forces with Labor Community Services (LCS) to support the...

PharmAla Files Preliminary Base Shelf Prospectus

Pharmala files short form prospectus

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced that it entered into a securities purchase agreement with an accredited investor for aggregate gross proceeds of $4.25 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for potential acquisitions, marketing and other general corporate purposes.

Avis Budget Group, Inc. (CAR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa., June 20, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead...

Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, June 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Elevance Health, Inc. ("Elevance"...

Krispy Kreme, Inc. (DNUT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, June 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Krispy Kreme, Inc. ("Krispy...

XRP can not only rise but also earn: holders can unlock new channels for passive income through JA Mining

The price of XRP has fluctuated violently, rising to $2.20 before falling back to about $2.15, affected by market's risk aversion. At the same time, the stablecoin RLUSD launched by Ripple was approved by Dubai, which strengthened its confidence in global expansion; a Chinese institution plans to invest $300 million in the purchase of XRP, highlighting its rising appeal. In addition, the dispute between Trump and Musk has also brought volatility to the market. XRP is still hovering around the key support level of $2.00, and the future direction depends on legal progress and ETF approval.
The price of XRP has fluctuated violently, rising to $2.20 before falling back to about $2.15, affected by market's risk aversion. At the same time, the stablecoin RLUSD launched by Ripple was approved by Dubai, which strengthened its confidence in global expansion; a Chinese institution plans to invest $300 million in the purchase of XRP, highlighting its rising appeal. In addition, the dispute between Trump and Musk has also brought volatility to the market. XRP is still hovering around the key support level of $2.00, and the future direction depends on legal progress and ETF approval.

OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules

OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules

Halozyme Announces argenx Received European Commission Approval for VYVGART® Subcutaneous Injection with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

SC injection of VYVGART® is available as a vial or prefilled syringe and can be administered by a patient, caregiver, or healthcare professional SAN DIEGO,...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPress release